New U.S. law requires better labeling on prescription drugs

A new piece of legislation called the "[CLEAR LABELS Act|noun]" has been introduced in the U.S.

conceptCLEAR LABELS Act

Senate.

This bill aims to improve transparency by requiring prescription drug labels to clearly list the "country of origin" for both the final medication and its "[Active Pharmaceutical Ingredients|noun]" (APIs).

conceptActive Pharmaceutical Ingredient

techAPI

While the "[FDA|organization]" supports increased supply chain transparency, some industry groups worry about the high costs and logistical burdens this might create for manufacturers.

orgFDA

Unlike current regulations, which focus on safety instructions and dosage, this act specifically targets "[geopolitical and manufacturing source|noun]" information.

conceptgeopolitical and manufacturing source

🎉

End of article

You read 5 focus sentences.

Challenge Mode

Comprehension Questions

What is the primary goal of the proposed CLEAR LABELS Act?

To disclose the country of origin for drugs and their ingredients.

To increase the speed of FDA drug approval processes.

To reduce the price of prescription medications for consumers.

Reveal Answer

✓

Correct Choice

To disclose the country of origin for drugs and their ingredients.

What specific information about ingredients does the act require on labels?

The chemical formula of the active ingredients.

The expiration dates of the chemical components.

The name and location of the manufacturer of the APIs.

Reveal Answer

✓

Correct Choice

The name and location of the manufacturer of the APIs.

Why are some groups concerned about the current labeling system?

It is difficult to know where a medication was actually manufactured.

Labels are currently too long and difficult to read.

Labels do not include enough dosage warnings.

Reveal Answer

✓

Correct Choice

It is difficult to know where a medication was actually manufactured.

How do existing FDA regulations primarily differ from the CLEAR LABELS Act?

Existing laws already require full origin transparency for all ingredients.

Existing laws focus on clinical usage instructions and patient safety.

Existing laws focus on the political alliances of the manufacturing country.

Reveal Answer

✓

Correct Choice

Existing laws focus on clinical usage instructions and patient safety.

Why do some pharmaceutical industry groups oppose the new bill?

They are concerned about the high costs and operational burdens.

They believe it does not go far enough in protecting consumers.

They think it will lead to an oversupply of generic medications.

Reveal Answer

✓

Correct Choice

They are concerned about the high costs and operational burdens.

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.

App Store Google Play